Gynecologic cancers-including ovarian, endometrial and cervical cancers-account for approximately 100,000 new cases and over 30,000 deaths per year in the United States. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective; therefore, most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality have been markedly increasing in recent years, due in large part to increasing obesity rates and other lifestyle factors. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease incidence and improve outcomes.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Gynecologic cancers-including ovarian, endometrial and cervical cancers-account for approximately 100,000 new cases and over 30,000 deaths per year in the United States. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective; therefore, most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality have been markedly increasing in recent years, due in large part to increasing obesity rates and other lifestyle factors. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease incidence and improve outcomes. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9783725877935
Anbieter: California Books, Miami, FL, USA
Zustand: New. Bestandsnummer des Verkäufers I-9783725877935
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9783725877935
Anzahl: Mehr als 20 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9783725877935
Anzahl: Mehr als 20 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Hardcover. Zustand: new. Hardcover. Gynecologic cancers-including ovarian, endometrial and cervical cancers-account for approximately 100,000 new cases and over 30,000 deaths per year in the United States. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective; therefore, most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality have been markedly increasing in recent years, due in large part to increasing obesity rates and other lifestyle factors. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease incidence and improve outcomes. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9783725877935
Anzahl: 1 verfügbar
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Hardcover. Zustand: new. Hardcover. Gynecologic cancers-including ovarian, endometrial and cervical cancers-account for approximately 100,000 new cases and over 30,000 deaths per year in the United States. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective; therefore, most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality have been markedly increasing in recent years, due in large part to increasing obesity rates and other lifestyle factors. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease incidence and improve outcomes. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Bestandsnummer des Verkäufers 9783725877935
Anzahl: 1 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Gynecologic cancers-including ovarian, endometrial and cervical cancers-account for approximately 100,000 new cases and over 30,000 deaths per year in the United States. The prevention and interception of these cancers would greatly impact outcomes and significantly reduce mortality rates. For ovarian cancer, screening in the general population is not considered effective; therefore, most cases of this cancer are diagnosed at a late stage with a poor survival rate. Endometrial cancer incidence and mortality have been markedly increasing in recent years, due in large part to increasing obesity rates and other lifestyle factors. Cervical cancer has had the benefit of the availability of both screening and prevention. Equity in the dissemination and implementation of these prevention and screening methods is essential for early diagnosis and treatment. These opportunities and challenges related to the diagnosis and high mortality of these gynecologic cancers emphasize the importance of identifying women at higher risk for these cancer types, and providing prevention/interception interventions to decrease incidence and improve outcomes. Bestandsnummer des Verkäufers 9783725877935
Anzahl: 2 verfügbar
Anbieter: preigu, Osnabrück, Deutschland
Buch. Zustand: Neu. Gynecologic Cancer | Risk Factors, Interception and Prevention | Buch | Englisch | 2026 | MDPI AG | EAN 9783725877935 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. Bestandsnummer des Verkäufers 135844889
Anzahl: 5 verfügbar